Brief: Zhongzhi Pharmaceutical Says HY Profit Attributable RMB134.9 Million, Increase Of 75.1%

Zhongzhi Pharmaceutical Holdings

23/08/2023 16:33

Aug 23 (Reuters) - Zhongzhi Pharmaceutical  3737.HK :
    * HY PROFIT ATTRIBUTABLE RMB134.9 MILLION, INCREASE OF 75.1%
    * HY REVENUE RMB1,094.3 MILLION, INCREASE OF 29.3%
    * RECOMMENDED TO DISTRIBUTE AND PAY AN INTERIM DIVIDEND OF
HK6
CENTS PER ORDINARY SHARE

Source text for Eikon:  ID:nHKS6BvH3Y 
Further company coverage:  3737.HK 

 ((Reuters.Briefs@thomsonreuters.com;))